x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:17:18

How Can We Destigmatize a Hepatitis B Diagnosis?...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/24

In episode 2 of this series, tune in to a conversation between Robert G. Gish, MD, and patient advocate Jacki Chen, PhD, about the potential benefits of simplifying our approach to treating patients with chronic hepatitis B. The conversation focuses on the stigma many patients experience following diagnosis and how access to treatment may reduce this.Presenter:Robert G. Gish, MDProfessor of MedicineLoma Linda UniversityLoma Linda, CaliforniaAdjunct Professor of Medicine Nevada School of Medicine

en

00:26:09

Lessons From Lockdown: Caring for Patients With...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/24

In this episode, Drs Norah Terrault, MD, MPH, and Grace LH Wong, MD, share lessons learned in the care of patients with hepatitis B virus (HBV) in the COVID-19 era, including:HBV cascade of care before vs during the pandemicInnovative strategies to improve HBV diagnosis and linkage to careLessons learned in telemedicineElimination through vaccinationManagement of HBV and COVID-19 coinfectionManagement of elevated liver enzymes in COVID-19Presenters:Norah Terrault, MD, MPHProfessor of MedicineChief

en

00:36:41

COVID-19: Omicron Transmissibility, Severity, and...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/22

In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses what is known about the SARS-CoV-2 omicron variant, including:Transmissibility and infectiousness Immune evasionDisease severity Risks of hospitalization and death Vaccine effectiveness 2- vs 3-dose vaccine effectivenessT-cell responsePresenter: Sharon R. Lewin, AO, FRACP, PhD, FAHMSDirector, The Peter Doherty Institute for Infection and ImmunityProfessor of Infectious DiseasesUniversity of MelbourneConsultant Infectious Diseases

en

00:10:40

Importance of Treatment for HBV: Patient and...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/18

In episode 6 of an ongoing series of sharing sessions between a physician and patient, Tarik Asselah, MD, PhD, and his patient, who is living with chronic hepatitis B (CHB), discuss:Importance and goals of hepatitis B virus (HBV) treatment, with a call for broader access to treatment worldwideScreening for HBV, especially given the frequency of asymptomatic diseaseHBV vaccination as a preventive measureLiving a healthy life and maintaining hope while living with CHBPresenter: Tarik Asselah, MD,

en

00:18:17

Key Decisions in HIV Care: Treating HIV/HCV Coinfection

Decera Clinical Education Infectious Disease Podcast ·

2022/02/16

In this episode, Mark S. Sulkowski, MD, explores recommendations and data on treating HIV and hepatitis C virus (HCV) in patients who are coinfected.Listen as he gives his perspectives on:Prioritization of both HIV and HCV treatmentEfficacy of HCV direct-acting antivirals in people with HIVAmerican Association for the Study of Liver Diseases/Infectious Diseases Society of America recommendations for first-line HCV treatment in HIV/HCV coinfectionInternational guidance on first-line antiretroviral

en

00:06:43

My Management Strategies for NASH in Patients With HIV

Decera Clinical Education Infectious Disease Podcast ·

2022/02/15

In this episode, Mark S. Sulkowski, MD, discusses his recommended approach for managing nonalcoholic steatohepatitis in patients with HIV, including recognizing nonalcoholic steatohepatitis, recommending lifestyle interventions, and considering pharmacologic approaches. Presenter:Mark S. Sulkowski, MDProfessor of MedicineMedical Director, Viral Hepatitis CenterChief, Infectious DiseaseJohns Hopkins Bayview Medical CenterJohns Hopkins University School of MedicineBaltimore, MarylandContent based on

en

00:29:44

Lessons From Lockdown: Hepatitis Delta Elimination...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/11

In this episode, Robert G. Gish, MD, and Pietro Lampertico, MD, PhD, share lessons learned in the care of patients coinfected with hepatitis B virus and hepatitis delta virus (HDV), including:Burden of HDV infectionChronic HDV infection and comorbiditiesImpact of COVID-19 on care of patients with chronic hepatitis BScreening for HDV and which assays to useScreening for viral hepatitis at a COVID-19 vaccination sitePresenters:Robert G. Gish, MD, FAASLD, AGAF, FASTProfessor of MedicineLoma Linda

en

00:30:37

Key Decisions in HIV Care: Renal and Hepatic...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/10

In this episode from the series “Key Decisions in HIV Care,” Jonathan Appelbaum, MD, FACP, AAHIVS, and Jens D. Lundgren, MD, DMSc, discuss important considerations for antiretroviral therapy (ART) use in older patients with renal and hepatic impairment.European AIDS Clinical Society guideline screening recommendations for kidney disease in people with HIVAntiretroviral dose adjustment recommendations based on estimated glomerular filtration rateData on the use of full-dose lamivudine with renal

en

00:37:30

Don’t Forget About the Liver! NASH in Patients with...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/09

In this episode, Jürgen K. Rockstroh, MD, and Giada Sebastiani, MD, discuss key strategies to appropriately screen for, identify, and manage nonalcoholic steatohepatitis in persons with HIV. They also answer pressing questions from healthcare professionals.Presenters: Jürgen K. Rockstroh, MDProfessor of MedicineUniversity Hospital BonnDepartment of Medicine IBonn, GermanyGiada Sebastiani, MDAssociate Professor of MedicineMcGill University Health CentreDivision of Gastroenterology and Hepatology and

en

00:05:36

NASH in PWH: Key Strategies for Screening and...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/03

In this episode, Jürgen K. Rockstroh, MD, discusses his recommended approach for diagnosing nonalcoholic steatohepatitis in patients with HIV, the value of noninvasive diagnostic tests such as serum biomarkers and elastography, and how timely nonalcoholic fatty liver disease assessment and metabolic risk factor determination can result in early interventions.Presenter:Jürgen K. Rockstroh, MDProfessor of MedicineUniversity Hospital BonnDepartment of Medicine IBonn, GermanyContent based on an online

en

00:17:56

Key Decisions in HIV Care: Considering the Use of...

Decera Clinical Education Infectious Disease Podcast ·

2022/02/01

In this episode, John D. Baxter, MD, explores recommendations and data on the use of proviral DNA genotyping to inform antiretroviral therapy (ART) choice for patients who are treatment experienced.Listen as he gives his perspectives on:US Department of Health and Human Services guideline recommendations on the use of proviral DNA genotypingUS Department of Health and Human Services guideline recommendations and supporting data on switching ART with viral suppression and underlying drug

en

00:39:05

Tackling Racial Inequities in HIV Care Globally

Decera Clinical Education Infectious Disease Podcast ·

2022/01/26

In this episode, Rageshri Dhairyawan, MBBS, BSc, FRCP, DipGUM, DFSRH, DipHIV, and Solange L. Baptiste, ScM, discuss the burden of HIV among BIPOC and migrant communities and key strategies to reduce racial disparities in HIV care globally:Disproportionate impact of HIV among BIPOC communities and migrant populations globallyBarriers to HIV testing, prevention, and treatment services among BIPOC communities and migrant populationsStrategies to overcome health system–based and provider-based barriers

en

00:17:33

Key Decisions in HIV Care: Choosing Initial ART in...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/25

In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance.Listen as he gives his perspectives on:Initial response to antiretroviral therapy during primary HIV infection with baseline resistanceData from the START study on treatment-naive patients with transmitted drug resistance by region and drug classRecommendations from the US Department of Health and Human Services and International AIDS Society–USA guidelines on

en

00:41:54

Omicron Variant: Effects on Treatments for COVID-19

Decera Clinical Education Infectious Disease Podcast ·

2022/01/25

The SARS-CoV-2 omicron variant has affected which of our COVID-19 treatment strategies are currently effective, with some expected to maintain their efficacy and some expected to lose their efficacy. In this episode, Arthur Kim, MD, discusses the effects of the SARS-CoV-2 omicron variant on many of the COVID-19 approved, authorized, and investigational treatment options, including:Direct-acting, small-molecule antiviral agents such as molnupiravir, nirmatrelvir + ritonavir, and

en

00:51:15

Tackling Racial Inequities in HIV Care in the United...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/12

In this episode, Samantha V. Hill, MD, MPH, and David Malebranche, MD, MPH, examine key facilitators to tackling racial inequities in HIV care, including:Barriers to HIV testing, prevention, and treatment services in BIPOC communities and migrant populationsFacilitators to HIV testing, prevention, and treatment services in BIPOC communities and migrant populationsStrategies to overcome health system–based and healthcare professional–based barriers to engagement with HIV careSamantha V. Hill, MD,

en

00:38:45

Key Decisions in HIV Care: ART Considerations With...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/10

In this episode from the series “Key Decisions in HIV Care,” Daria Podlekareva, MD, PhD, and Mark S. Sulkowski, MD, discuss important considerations for ART use in patients with coinfections, including:DHHS testing and treatment recommendations for HBV in patients with HIVData suggesting that tenofovir alone may not suppress HBV in all PWHData from NA-ACCORD showing that incomplete HBV DNA suppression is associated with HCC in patients with HIV/HBVData for the use of entecavir as an add-on therapy

en

00:07:55

Key Decisions in HIV Care: Is There a Role for PIs in...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/06

In this episode, Karen Ha, MD, explores recommendations and data on the role of PIs in current practice.Listen as she gives her perspectives on:DHHS guideline recommendations on the use of PI-based ARTData from the DIAMOND study on the use of boosted DRV for rapid initiationData from the EARNEST and NADIA studies on the use of PI-based ART with NRTI resistanceConsiderations for the use of PIs in patients with cardiovascular risk, including data from the D:A:D studyKey drug–drug interaction

en

00:09:12

Key Decisions in HIV Care: Is There a Role for NNRTIs...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/06

In this episode, Karen Ha, MD, explores recommendations and data on the role of NNRTIs in current practice.Listen as she gives her perspectives on:DHHS guideline recommendations on the use of NNRTI-based ARTWeight gain data from the ADVANCE study, DRIVE-AHEAD, DRIVE-FORWARD, DRIVE-SHIFT, and a multivariate analysis of weight gain on ARTKey food effects and drug–drug interaction considerations with the use of NNRTIsPresenter:Karen Ha, MDAssistant Professor of MedicineDivision of Infectious

en

00:37:06

COVID-19 Oral Antiviral Agents

Decera Clinical Education Infectious Disease Podcast ·

2022/01/06

In this episode, Renslow Sherer, MD, discusses key data on COVID-19 oral antiviral agents—molnupiravir and nirmatrelvir (PF-07321332) plus ritonavir—for nonhospitalized adults with mild to moderate COVID-19, including:EPIC-HR study of nirmatrelvir (PF-07321332) plus ritonavirSafety dataEfficacy dataMOVe-OUT study of molnupiravirSafety dataEfficacy dataRoles in treatment of COVID-19Timing of treatmentPresenter:Renslow Sherer, MDDirector, International HIV Training CenterProfessor of MedicineSection

en

00:08:27

Personal Perspectives on HIV PrEP Use: My Decision,...

Decera Clinical Education Infectious Disease Podcast ·

2022/01/03

In this episode, Christian R. Pollard provides his perspectives as an individual taking daily oral HIV PrEP, including factors he considered in the decision to use PrEP, his experience with taking PrEP (daily pills and periodic laboratory testing), and his thoughts on what opportunities future PrEP options may offer.Presenter:Christian R. PollardContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College